+0.32%
Today
Loading 1D prices…
Company profile
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Mahwah, NJ, United States
Employees
73
Fiscal year end
1231
CIK
704440
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LUCDLucid Diagnostics Inc. Common Stock | $149.5M | $4.7M | -1232.68% | -$0.43 | -2.99% | Buy |
| NYXHNyxoah SA Ordinary Shares | $156.8M | — | — | -$2.36 | +2.67% | Hold |
| APYXApyx Medical Corporation Common Stock | $122.2M | $52.8M | -21.22% | -$0.27 | +0.35% | Buy |
| PDEXPro-Dex Inc. Common Stock | $201.2M | $77.5M | +17.62% | $4.12 | +4.96% | Hold |
| PYPDPolyPid Ltd. Ordinary Shares | $104.6M | $0.00 | — | $2.09 | -0.19% | Buy |